Filing Details
- Accession Number:
- 0001209191-20-058031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:05:02
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 17:05:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1755237 | Cyclerion Therapeutics Inc. | CYCN | Pharmaceutical Preparations (2834) | 831895370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775029 | Andreas Busch | C/O Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge MA 02142 | Chief Innovation Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-09 | 125,000 | $2.53 | 254,704 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.60, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.
- The reporting person acquired 2,204 and 2,500 shares of Common Stock under the issuer's employee stock purchase plan on November 29, 2019 and May 29, 2020, respectively.
Billionaire Hedge Funds
